BackCytRx Overview

CytRx Accounts Payable

Latest accounts payable for CYTR: $1.1B.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$1.10B

Peer average

Loading

CytRx Accounts Payable History

Loading

CytRx vs. peers: Accounts Payable Comparison

Loading

CytRx Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

CytRx (CYTR) FAQ

As of the most recent data (March 2025), CYTR shows a accounts payable of $1.1B. Scroll down for historical charts and peer comparison views.

Tracking CYTR's accounts payable over time shows whether CytRx is scaling, shrinking, or reshaping that part of the business. The current reading is $1.1B Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has CytRx's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $1.1B) with ownership activity and broader fundamentals.

CytRx's accounts payable is $1.1B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.